Foley Hoag LLP advised HiFiBiO Therapeutics on the deal. FibroGen, Inc. (Nasdaq: FGEN) and HiFiBiO Therapeutics, a private, multinational clinical-stage biotherapeutics company with expertise in immune...
FibroGen’s Partnership with HiFiBiO Therapeutics
Ginkgo Bioworks’ Collaboration and License Agreement with Biogen
Foley Hoag LLP advised Ginkgo Bioworks on the deal. Ginkgo Bioworks, Inc., the organism company, closed a collaboration and license agreement with Biogen (Nasdaq: BIIB) to...
Ginkgo Bioworks’ Collaboration and License Agreement with Biogen
Foley Hoag LLP advised Ginkgo Bioworks on the deal. Ginkgo Bioworks, Inc., the organism company, closed a collaboration and license agreement with Biogen (Nasdaq: BIIB) to...